Latest News & Features
Refine search
MedTech
The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product. 27 October 2026
Careers
The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies. 27 October 2026
In-house counsel
Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch. 26 October 2026
Careers
After introducing Microsoft Copilot and specialist legal AI platforms Solve Intelligence and Legora, the firm says the chief technology officer’s priorities will include expanding the use of AI in patent and legal work. 26 October 2026
Biotech
Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win. 23 October 2026
Pharma
Questions over what Boehringer’s patents actually proved dominated the final day of the hearing, but a push for a further finding raised the stakes, with a possible appeal threatening to keep Dr Reddy’s off the market even if it won. 22 October 2026
Pharma
Following a major US Supreme Court win for generics, the landmark dispute has finally come to an end. A new filing brings closure to a case that raised questions over skinny labelling and induced patent infringement. 22 October 2026
In-house counsel
From building IP teams that are business orientated to tackling M&A challenges, the global head of IP management at Medmix Group—a manufacturer of high-precision delivery, mixing and application devices—explains why close collaboration, trusted external counsel and thorough due diligence matter. 21 October 2026
Careers
With specialisms covering AI, electrical, manufacturing and engineering, the pair move from Brownstein, following a former colleague who joined the firm earlier this year. 21 October 2026
MedTech
A panel rejected the Omnipod maker’s request for a rehearing in its trade secrets dispute with South Korean insulin pump maker EOFlow, leaving in place a ruling that overturned a $59.4 million damages award and raising questions over the three-year statute of limitations under the DTSA. 20 October 2026


